Characterization of the Colibactin-Activating Peptidase ClbP Enables Design of a Fluorogenic Activity Probe.

08:00 EDT 14th August 2019 | BioPortfolio

Summary of "Characterization of the Colibactin-Activating Peptidase ClbP Enables Design of a Fluorogenic Activity Probe."

No Summary Available


Journal Details

This article was published in the following journal.

Name: ACS chemical biology
ISSN: 1554-8937


DeepDyve research library

PubMed Articles [11415 Associated PubMed Articles listed on BioPortfolio]

In vitro characterization of the colibactin-activating peptidase ClbP enables development of a fluorogenic activity probe.

The gut bacterial genotoxin colibactin is linked to the devel-opment of colorectal cancer. In the final stages of colibactin's biosynthesis, an inactive precursor (precolibactin) undergoes proteolytic...

Unveiling the Mutational Mechanism of the Bacterial Genotoxin Colibactin in Colorectal Cancer.

In a recent issue of Science, Wilson et al. (2019) provide direct evidence that the bacterial-produced colibactin alkylates DNA in vivo, resulting in DNA adducts, which mediates its genotoxic effect...

"Second-generation" fluorogenic RNA-based sensors.

A fluorogenic aptamer can specifically interact with a fluorophore to activate its fluorescence. These nucleic acid-based fluorogenic modules have been dramatically developed over the past decade, and...

Chronic low back pain beliefs and management practices in Africa: Time for a rethink?

Chronic low back pain (CLBP) beliefs are important psychosocial risk factors affecting the occurrence and progression of CLBP. To address pain beliefs and implement recommended biopsychosocial approac...

Designing a green fluorogenic protease reporter by flipping a beta strand of GFP for imaging apoptosis in animals.

A family of proteases called caspases mediate apoptosis signaling in animals. Here, we report design and characterization of a GFP-based fluorogenic protease reporter, dubbed "FlipGFP". FlipGFP is rat...

Clinical Trials [2499 Associated Clinical Trials listed on BioPortfolio]

Non Invasive Brain Stimulation Treatment for CLBP

This trial is designed to preliminary evaluate the efficacy and safety of NIBS system for treatment of chronic low back pain (CLBP) (over 6 months). The trial is of a double blind sham con...

A Trial Comparing Mechanical Diagnosis and Treatment to Manual Therapy

Mechanical diagnosis and treatment (MDT) and Manual Therapy (MT) have both demonstrated efficacy in the management of CLBP. The use of a Point of Care (POC) design in this study will allow...

Safety of Acupuncture Treatments for Chronic Low Back Pain in Older Adults

Acupuncture, along with other complementary and integrative treatments, is commonly used as a complementary or integrative therapy when treating a multitude of pain complaints, including c...

Yoga for Chronic Low Back Pain and Its Mechanism of Action: Impact of Strength and Stretch (YoMA II)

This study is a pilot, randomized controlled trial to provide feasibility and conduct preliminary analyses on physical (strength and stretch) mechanisms associated with a yoga intervention...

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

The purpose of this study is to demonstrate the secretion of glucose, insulin, glucagon, C-peptide and lipid profile after isocaloric diets with different nutritional compounds (fat, prote...

Medical and Biotech [MESH] Definitions

An approach, process, or methodology which emphasizes credible evidence and the best available scientific knowledge, judiciously integrated to achieve the best possible outcomes in structural design. For example, the design of a new OUTPATIENT CLINIC might incorporate a review of published research on outpatient clinic design, decisions on similar past projects, along with interviews with staff and consumers.

A family of serine peptidase inhibitors that occur in animals, some single-cell eukaryotes, and higher plants. They contain variable numbers of KAZAL MOTIFS and inhibit SERINE ENDOPEPTIDASES such as ACROSIN and TRYPSIN.

A serine protease that catalyses the release of an N-terminal dipeptide. Several biologically-active peptides have been identified as dipeptidyl peptidase 4 substrates including INCRETINS; NEUROPEPTIDES; and CHEMOKINES. The protein is also found bound to ADENOSINE DEAMINASE on the T-CELL surface and is believed to play a role in T-cell activation.

Architecture, exterior and interior design, and construction of facilities other than hospitals, e.g., dental schools, medical schools, ambulatory care clinics, and specified units of health care facilities. The concept also includes architecture, design, and construction of specialized contained, controlled, or closed research environments including those of space labs and stations.

Compounds that supress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.

Quick Search

DeepDyve research library

Searches Linking to this Article